Psödokolinesteraz Eksikliğine Bağlı Uzamış Apne Gelişen Elektrokonvülsif Terapi Olgusunda Roküronyum—Sugammadeks Kullanımı
Süksinilkolin hızlı başlangıç ve kısa etki süresi nedeniyle elektrokonvülsif tedavi (EKT) sırasında kas gevşemesi için yaygın olarak kullanılmaktır. Ancak bazen psödokolinesteraz eksikliğine bağlı uzamış apne gibi istenmeyen yan etkilerle karşılaşılabilmektedir. Süksinilkolin kullanımının uygun olmadığı vakalarda süksinilkolin kadar hızlı etki başlama ve hızlı derlenme gereken kas gevşeticilere gereksinim vardır. Bu amaçla son yıllarda kullanılmaya başlanan gama--siklodekstrin yapısında olan sugammadeks; rokuronyum moleküllerini plazmada ve nöromusküler kavşakta bire bir bağlayarak derin nöromüsküler bloğu hızlı bir şekilde sonlandırmaktadır. Bu olgu sunumuzda ilk EKT sırasında psödokolinesteraz eksikliğine bağlı uzamış apne gelişen hastanın tekrarlayan seanslarda roküronyum--sugammadeks kullanımı ile ilgili deneyimimizi paylaşmayı amaçladık. Sonuç olarak roküronyum ve sugammadeks EKT gibi kısa işlem gerektiren vakalarda güvenle kullanılabileceği kanısındayız.
Use of Rocuronium—Sugammadex in Patient who Prolonged Apnea Due to Pseudocholinesterase Deficiency During ECT
Succinylcholine is widely used for muscle relaxation during Electroconvulsive therapy (ECT) mowing to its rapid onset and short duration of action. However, untoward side effects may occasionally occur, such as prolonged apnea associated with pseudocholinesterase deficiency. In cases where use of succinylcholine is inappropriate, muscle relaxants are needed to achieve rapid onset of action and fast recovery equal to that is observed with succinylcholine. Sugammadex has gamma-cyclodextrin structure, and binds to the rocuronium molecules in plasma and neuromuscular junction tightly in one to one fashion and quickly inhibits the deep neuromuscular block. In this case report, we aimed to share our experience in the use of rocuronium—sugammadex during repeated sessions in patient who experienced prolonged apnea associated with pseudocholinesterase deficiency during the first ECT. In conclusion, we believe that rocuronium and sugammadex may be used with confidence in cases requiring short procedures such as ECT.
___
- 1. Churchill—Davidson HC. Suxamethonium (succinylcholine) chloride and muscle pains. BMJ 1954;1:74-5.
- 2. Allen TK, Habib AS, Dear GL, White W, Lubarsky DA, Gan TJ. How much are patients willing to pay to avoid postoperative muscle pain associated with succinylcholine Clin Anesth 2007;19:1—8.
- 3. Lee C, Jahr JS, Candiotti KA, Warriner B,Zornow MH, Naguib M. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: comparison with spontaneous recovery from succinylcholine. Anesthesiology 2009;110:1020—5.
- 4. Williamson RM, Mallaiah S, Barclay P. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia. Acta Anaesthesiol Scand 2011;55:694-9.
- 5. Mirzakhani H, Welch CA, Eikermann M, Nozari A. Neuromuscular blocking agents for electroconvulsive therapy: systematic review. Acta Anaesthesiol Scand 2012;56:3—16.
- Morgan GE, Mishael MS, Murray MJ. Nöromusküler Bloke Edici ilaçlar. Çev. Ed. Tulunay M, Cuhruk H. Klinik Anesteziyoloji. 4. Baskı. Ankara: Güneş Kitapevi; 2008. p. 205—27.
- Berry M, Whittaker M. Incidence of suxamethonium apnoea in patients undergoing ECT. BrJ Anaesth 1975;47:1195-7.
- Hicks FG. ECT Modified by Atracurium. Convusl Ther 1987;3:54—9.
- Turkkal DC, Gokmen N, Yildiz A, Iyilikci L, Gokel E, Sagduyu K, Gunerli A. cross—over, post—electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine. Clin Anesth 2008;20:589—93.
- Hoshi H, Kadoi Y, Kamiyama J, Nishida A, Saito H, Taguchi M, Saito S. Use of rocuronium—sugammadex, an alternative to succinylcholine, as muscle relaxant during electroconvulsive therapy. Anesth 2011;25:286-90.
- Kadoi Y, Hoshi H, Nishida A, Saito S. Comparison of recovery times from rocuronium—induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy. Anesth 2011;25:855—9. Received/Başvuru: 16.07.2013, Accepted/Kabul: 30.07.2013